Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23.3Revenue $M46.9Net Margin (%)--Altman Z-Score1.1
Enterprise Value $M11.1EPS $-0.5Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.9Pre-tax Margin (%)--Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %-49.7Quick Ratio11.2Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-45.3Current Ratio11.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-55.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-59.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ABIO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABIOFirst Eagle Investment 2010-03-31 Sold Out -0.01%$15.84 - $49.32
($19.1)
$ 1.10-94%Sold Out0
ABIOFirst Eagle Investment 2009-12-31 Reduce$13.5 - $25.92
($18.08)
$ 1.10-94%Reduce 27.96%68,720
ABIOFirst Eagle Investment 2009-09-30 Add0.01%$13.68 - $26.4
($20.88)
$ 1.10-95%Add 62.38%95,387
ABIOFirst Eagle Investment 2009-06-30 Sold Out -0.02%$15.48 - $80.7
($41.17)
$ 1.10-97%Sold Out0
ABIOFirst Eagle Investment 2009-06-30 Add$15.48 - $80.7
($41.17)
$ 1.10-97%Add 24.34%58,742
ABIOFirst Eagle Investment 2009-03-31 Buy 0.02%$23.399 - $39.41
($31.32)
$ 1.10-96%New holding47,242
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABIO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ABIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BRISTOW MICHAEL RSee Remarks 2015-03-02Sell5,446$0.7154.93 view
Selby Brian L.VP, Finance 2015-03-02Sell1,125$0.7154.93 view
mccormack riley10% Owner 2015-01-16Sell350,000$0.7644.74 view
mccormack riley10% Owner 2015-01-07Sell550,000$0.9219.57 view
Wheeler Patrick MCFO 2014-09-18Sell8,246$1.31-16.03 view
BRISTOW MICHAEL RPresident and CEO 2014-09-18Sell13,853$1.3-15.38 view
mccormack riley10% Owner 2014-02-04Buy1,000,000$1.7-35.29 view
mccormack riley10% Owner 2013-09-27Sell0$0-35.29 view
Atlas Venture Fund VII L P10% Owner 2012-10-25Sell0$0-35.29 view
Grais Linda SDirector 2010-03-29Sell210,809$7.38-85.09 view

Quarterly/Annual Reports about ABIO:

News about ABIO:

Articles On GuruFocus.com
comment on ABIO Mar 15 2013 
ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Nov 15 2010 
ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Aug 10 2010 
ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) May 10 2010 
ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Nov 16 2009 
ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Aug 10 2009 
ARCA biopharma Inc. Reports Operating Results (10-Q) May 15 2009 
ARCA biopharma Inc. Reports Operating Results (10-Q) Feb 07 2009 

More From Other Websites
Nutritional Supplement Industry Flexes its Muscles as Natural & Pharmaceutical Supplement Products... Jun 29 2015
RA Capital Is Expecting A Breakthrough Cancer Drug From This Biotech Jun 29 2015
ARCA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 23 2015
ARCA biopharma Announces $37 Million Private Placement Jun 17 2015
ARCA biopharma Announces Closing of $37 Million Private Placement Jun 17 2015
ARCA biopharma Announces Closing of $37 Million Private Placement Jun 17 2015
ARCA biopharma Announces $37 Million Private Placement Jun 12 2015
ARCA BIOPHARMA, INC. Files SEC form 8-K/A, Financial Statements and Exhibits Jun 11 2015
ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered... Jun 11 2015
ARCA biopharma Announces $37 Million Private Placement Jun 11 2015
ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events Jun 05 2015
ARCA BIOPHARMA, INC. Financials May 22 2015
10-Q for ARCA biopharma, Inc. May 14 2015
ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report May 12 2015
10-K for ARCA biopharma, Inc. May 02 2015
ARCA biopharma Gains on Fast Track Status for Gencaro - Analyst Blog Apr 14 2015
ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 13 2015
ARCA biopharma (ABIO) Stock Surges Today on FDA Fast Track Designation Apr 13 2015
ARCA biopharma Receives FDA Fast Track Designation for Gencaro™ Atrial Fibrillation Development in... Apr 13 2015
ARCA biopharma Provides GENETIC-AF Clinical Trial Update Mar 20 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK